Flagship Pioneering is creating breakthroughs in human health and sustainability and building bioplatform companies through VC investing. Over two decades, Flagship has founded more than 100 science-based businesses worth more than $30 billion in aggregate value. Flagship’s portfolio already includes Moderna, Tessera Therapeutics, Generate Biomedicines and Indigo Agriculture to name only a few. Their approach combines innovative capacity, entrepreneurial leadership and professional capital management.
Flagship conceives, creates, resources and develops life science companies by starting with seemingly unreasonable propositions and navigating to transformational outcomes.